UK markets closed

Innate Pharma S.A. (0EVI.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
2.2050+0.0125 (+0.57%)
At close: 04:04PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) 178.26M
Enterprise value 125.69M
Trailing P/E 13.89
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.43
Price/book (mrq)3.45
Enterprise value/revenue 2.42
Enterprise value/EBITDA -68.35

Trading information

Stock price history

Beta (5Y monthly) 0.60
52-week change 3-18.19%
S&P500 52-week change 322.38%
52-week high 33.2600
52-week low 30.0000
50-day moving average 32.2378
200-day moving average 32.4255

Share statistics

Avg vol (3-month) 3953
Avg vol (10-day) 3418
Shares outstanding 580.63M
Implied shares outstanding 680.63M
Float 830.31M
% held by insiders 124.80%
% held by institutions 19.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin -119.90%
Operating margin (ttm)-48.42%

Management effectiveness

Return on assets (ttm)-6.60%
Return on equity (ttm)-71.91%

Income statement

Revenue (ttm)52.28M
Revenue per share (ttm)0.65
Quarterly revenue growth (yoy)-11.80%
Gross profit (ttm)N/A
EBITDA -19.19M
Net income avi to common (ttm)-62.63M
Diluted EPS (ttm)-0.7800
Quarterly earnings growth (yoy)-72.70%

Balance sheet

Total cash (mrq)88.89M
Total cash per share (mrq)1.1
Total debt (mrq)40.66M
Total debt/equity (mrq)70.27%
Current ratio (mrq)3.84
Book value per share (mrq)0.72

Cash flow statement

Operating cash flow (ttm)-31.84M
Levered free cash flow (ttm)-25.52M